Swara Baby Products, Backed by FirstCry, Gets SEBI Approval for ₹1,000 Crore IPO
Swara Baby Products, the diaper maker majority-owned by FirstCry parent Brainbees Solutions, has received the go-ahead from the Securities and Exchange Board of India (SEBI) for its ₹1,000 crore initial public offering.
According to SEBI’s processing status update, the regulator issued its final observations on the company’s draft papers on 6 October 2026, about three months after Swara filed its draft red herring prospectus (DRHP) on 2 July.
If the name doesn’t ring a bell, that isn’t surprising. Most of what Swara makes doesn’t carry its own name. It is mainly a contract manufacturer, producing diapers, sanitary napkins, and other hygiene products that other companies sell under their own labels.
In its DRHP, citing an industry report, the company says it was India’s largest hygiene contract manufacturer by value in FY25.
Who Is Swara Baby?
Founded in 2018 by Alok Birla, Rahul Bubna and Ritum Jain, Swara makes disposable hygiene products in three categories: baby care, adult incontinence and feminine hygiene. The range covers pant-style and tape-style baby diapers, adult diapers, sanitary napkins and panty liners.
Baby diapers are the heart of the business, bringing in about 79% of FY26 revenue, with adult diapers making up roughly 16%. Alongside its contract work, the company sells two brands of its own, Cuddles (baby diapers) and Shield (adult diapers), through e-commerce and modern retail.
Swara runs four plants across about 24 acres in Pithampur and Indore, Madhya Pradesh. Together they have the capacity to make roughly 266 crore baby diapers, 25.3 crore adult diapers, and 75.6 crore sanitary napkins and panty liners a year.
Its customers include Brainbees itself, Piramal Pharma, and Himalaya Wellness, a mix of retail and healthcare names. In December 2025, it bought K.A. Enterprises Hygiene Pvt Ltd (KAEHPL).
The FirstCry Connection
Brainbees Solutions, the company behind FirstCry, owns about 76.6% of Swara ahead of the IPO. The Alok Birla family and the Kanta Devi Birla Trust together hold roughly 22.3%.
That makes this a FirstCry subsidiary IPO rather than a minority bet, and the second FirstCry-backed IPO to come to market after Brainbees’ own listing in August 2024.
For Brainbees, a technology-led parenting retailer, selling part of its stake unlocks value from a factory business that also stocks its own shelves.
Swara Baby IPO Size and Structure
The Swara Baby IPO size is ₹1,000 crore, split evenly between new and existing shares:
- Fresh issue: up to ₹500 crore. This money goes to the company.
- Offer for sale (OFS): up to ₹500 crore. This money goes to the selling shareholders, not the company. Brainbees will sell up to ₹300 crore worth of shares and Anadya Bon Merchari LLP up to ₹200 crore.
Swara may also raise up to ₹100 crore through a pre-IPO placement, in which case the fresh issue will shrink by the same amount. JM Financial and Avendus Capital are the book-running lead managers.
Where the Money Will Go
Of the fresh-issue proceeds:
- ₹198.2 crore will fund a new manufacturing facility in Pithampur, Madhya Pradesh.
- ₹100 crore will go towards repaying or prepaying borrowings.
- ₹27.5 crore will be invested in subsidiaries Solis Hygiene, Swara Hygiene and KAEHPL to help them repay their own debt.
- The rest is set aside for acquisitions and general corporate purposes.
Put simply, the plan is more capacity and less debt. It is not about new stores or a bigger digital push.
Financial Snapshot
On the finance side, Swara has been growing at a steady clip:
Particulars (₹ crore) | FY25 | FY26 | Change |
Revenue from operations | 943.0 | 1,163.9 | +23.4% |
Profit after tax | 80.7 | 95.6 | +18.5% |
Net margin | 8.6% | 8.2% | −0.4 pts |
Profit grew a little more slowly than revenue, so net margin slipped slightly, from about 8.6% to 8.2%.
Swara Baby SEBI Approval: What Happens Next
The Swara Baby SEBI approval means the regulator has finished reviewing the draft papers. It isn’t a verdict on the company’s quality or valuation. Under SEBI rules, Swara generally has 12 months from the date of the observation letter to open the issue.
Before that, it must file a red herring prospectus with the price band and issue dates. Neither has been announced yet.
What Investors Should Watch
- Client dependence. As a contract manufacturer, Swara avoids the heavy marketing spend that consumer brands carry, but its growth is tied to the brands it makes products for.
- Related-party dealings. Brainbees is both the majority owner and a customer, so the terms of that relationship deserve a close read in the final prospectus.
- The small dip in FY26 net margin is worth tracking as the new plant comes up.
- Nothing can be judged until the price band is set.
Key Details at a Glance
Parameter | Details |
Issuer | Swara Baby (hygiene products contract manufacturer) |
Majority shareholder | Brainbees Solutions (FirstCry), about 76.6% |
Total issue size | ₹1,000 crore |
Structure | Fresh issue up to ₹500 crore + OFS up to ₹500 crore |
DRHP filed | 2 July 2026 |
SEBI final observations | 6 October 2026 |
Use of fresh issue | New Pithampur plant, debt repayment, subsidiaries, acquisitions and general corporate purposes |
Book-running lead managers | JM Financial, Avendus Capital |
Price band and dates | Not announced yet |
Summary
With SEBI’s nod in hand, Swara is one step closer to the stock market. It is a profitable, growing manufacturer in an everyday category, backed by a parent that has already gone public.
What investors don’t know yet is the price, and that will decide whether the Swara Baby Products IPO is worth a look once it opens.
Frequently Asked Questions (FAQ's)
1. What is the Swara Baby IPO size?
₹1,000 crore: a fresh issue of up to ₹500 crore and an offer for sale of up to ₹500 crore.
2. Who backs Swara Baby?
Brainbees Solutions, FirstCry’s parent, owns about 76.6% of the company, which makes this a FirstCry subsidiary IPO.
3. When did SEBI approve the IPO?
SEBI issued its final observations on 6 October 2026.
4. What will the money be used for?
A new plant in Pithampur (₹198.2 crore), debt repayment (₹100 crore), investment in subsidiaries (₹27.5 crore), and acquisitions and general corporate purposes. OFS money goes to the selling shareholders.
5. When will the IPO open?
Not announced yet. The dates and price band will come with the red herring prospectus.
